Ketamine Expert Dr. Reid Robison On Clinical Trials, Ketamine For Eating Disorders, And Novamind’s Plans For Growth Jan 26, 2022
Awakn Life Sciences Files Patent Application for a New Class of Entactogen-Like Molecules to Treat a Broad Range of… Jan 26, 2022
Mindcure’s Kelsey Ramsden: Despite Market Slump, ‘Everything Is Moving In The Right Direction’ For Psychedelics Jan 25, 2022
Liquid Meta Partners with Civic Technologies to Bring Capital Liquidity to Permissioned dApps Jan 25, 2022
Mindset Pharma Enters Manufacturing Agreement with Leading CDMO to Produce Pharmaceutical Grade Batches of… Jan 25, 2022